Viruses (Sep 2022)

An Adenoviral Vector as a Versatile Tool for Delivery and Expression of miRNAs

  • Jonas Scholz,
  • Patrick Philipp Weil,
  • Daniel Pembaur,
  • Georgia Koukou,
  • Malik Aydin,
  • Dorota Hauert,
  • Jan Postberg,
  • Florian Kreppel,
  • Claudia Hagedorn

DOI
https://doi.org/10.3390/v14091952
Journal volume & issue
Vol. 14, no. 9
p. 1952

Abstract

Read online

Only two decades after discovering miRNAs, our understanding of the functional effects of deregulated miRNAs in the development of diseases, particularly cancer, has been rapidly evolving. These observations and functional studies provide the basis for developing miRNA-based diagnostic markers or new therapeutic strategies. Adenoviral (Ad) vectors belong to the most frequently used vector types in gene therapy and are suitable for strong short-term transgene expression in a variety of cells. Here, we report the set-up and functionality of an Ad-based miRNA vector platform that can be employed to deliver and express a high level of miRNAs efficiently. This vector platform allows fast and efficient vector production to high titers and the expression of pri-miRNA precursors under the control of a polymerase II promoter. In contrast to non-viral miRNA delivery systems, this Ad-based miRNA vector platform allows accurate dosing of the delivered miRNAs. Using a two-vector model, we showed that Ad-driven miRNA expression was sufficient in down-regulating the expression of an overexpressed and highly stable protein. Additional data corroborated the downregulation of multiple endogenous target RNAs using the system presented here. Additionally, we report some unanticipated synergistic effects on the transduction efficiencies in vitro when cells were consecutively transduced with two different Ad-vectors. This effect might be taken into consideration for protocols using two or more different Ad vectors simultaneously.

Keywords